MedPath

Observation on the Therapeutic Effect of Acupuncture Shenting and Baihui Combined with Repeated Transcranial Magnetic Stimulation on First-Episode Schizophrenia and Its Mechanism

Phase 1
Conditions
Schizophrenia
Registration Number
ITMCTR2100004236
Lead Sponsor
The Second People's Hospital of Lishui
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Meet the diagnostic criteria of schizophrenia, with stable condition, clear consciousness and stable vital signs;
2. The total score of the Positive and Negative Symptom Scale (PANSS) > 60 points;
3. It is the first time that he has not taken any antipsychotic drugs;
4. Age between 18 and 45 years old;
5. Han people, right-handed;
6. 18 years old <= age <= 75 years old;
7. The patient or legal guardian agrees and has signed an informed consent form.

Exclusion Criteria

1. Received MECT, rTMS treatment within 1 month
2. Contraindications for transcranial magnetic stimulation such as cardiac pacemakers, intracranial metal, aneurysm clips, etc.;
3. A history of craniocerebral disease (stroke, brain injury, meningitis, tumor, etc.), a history of epilepsy;
4. Patients with severe heart, liver, kidney, endocrine system and hematopoietic system diseases;
5. Pregnant and lactating women;
6. Those who are participating in other clinical trials that affect the evaluation of the results of this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mental symptoms;
Secondary Outcome Measures
NameTimeMethod
Cognitive function;
© Copyright 2025. All Rights Reserved by MedPath